Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Open Label”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04181788
What this trial is testing

Sasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced Malignancies

Who this might be right for
Advanced MalignanciesNon-small-cell Lung Cancer
Pfizer 155
Early research (Phase 1)Study completedNCT07691203
What this trial is testing

Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCl 25 mg/5 mg/1000 mg Extended Release Tablet Versus Trijardy® XR 25 mg/5 mg/1000 mg Extended- Release Tablets

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Cardiovascular Diseases
Humanis Saglık Anonim Sirketi 36
Testing effectiveness (Phase 2)Study completedNCT01685203
What this trial is testing

Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
AbbVie (prior sponsor, Abbott) 316
Early research (Phase 1)Study completedNCT03409627
What this trial is testing

Novel INXN-4001 Triple Effector Plasmid in Heart Failure

Who this might be right for
Heart FailureCardiovascular DiseasesHeart-Assist Device
Triple-Gene, LLC 12
Early research (Phase 1)Study completedNCT05028127
What this trial is testing

Evaluate the Relative Bioavailability and Tolerability of Bimekizumab in Healthy Subjects

Who this might be right for
Healthy Volunteers
UCB Celltech 12
Early research (Phase 1)Study completedNCT07269327
What this trial is testing

An Ethno-bridging Study of Pergoveris in Healthy Premenopausal Participants of Japanese or Caucasian Origin

Who this might be right for
Fertility
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT06004661
What this trial is testing

Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Novartis Pharmaceuticals 23
Not applicableUnknownNCT04500886
What this trial is testing

Evaluate the Efficacy and Safety of PEG-rhG-CSF in Patients With Hemophagocytic Syndrome

Who this might be right for
Hemophagocytic Syndrome
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. 50
Post-approval studies (Phase 4)Ended earlyNCT03262142
What this trial is testing

Targeted AntiBiotics for Chronic Pulmonary Diseases

Who this might be right for
COPDRespiratory Tract InfectionsPseudomonas Aeruginosa+2 more
Chronic Obstructive Pulmonary Disease Trial Network, Denmark 51
Not applicableWithdrawnNCT00908986
What this trial is testing

Open Label Pilot Trial of Rituximab in Lupus Membranous Nephritis

Who this might be right for
Lupus Nephritis
Northwell Health
Large-scale testing (Phase 3)Not Yet RecruitingNCT07739186
What this trial is testing

A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody Versus Tislelizumab Plus Platinum-doublet Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer(PANKU-Lung06)

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 120
Post-approval studies (Phase 4)UnknownNCT00727870
What this trial is testing

Evaluation of Preferences of Consumers and Clinicians for the Management of Shave Biopsy Sites With a PolyMem Formulation Dressing or Current Standard of Care.

Who this might be right for
Healing
Ferris Mfg. Corp. 90
Early research (Phase 1)Study completedNCT05852769
What this trial is testing

Evaluate the Drug-drug Interaction Potential of BMS-986196 in Healthy Participants

Who this might be right for
Healthy Volunteers
Bristol-Myers Squibb 18
Testing effectiveness (Phase 2)Looking for participantsNCT07222969
What this trial is testing

A Clinical Study to Evaluate the Safety of VIB305 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Vibrant Sciences Limited 146
Early research (Phase 1)Ended earlyNCT03246854
What this trial is testing

DBPR112 in Patients With Head and Neck Cancer and EGFR Mutated Lung Cancer

Who this might be right for
Head and Neck CancerNSCLC
National Health Research Institutes, Taiwan 6
Large-scale testing (Phase 3)Study completedNCT00195754
What this trial is testing

A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER in Subjects Who Either Completed or Prematurely Discontinued Due to Ineffectiveness From Study M02-488.

Who this might be right for
Migraines
Abbott 114
Post-approval studies (Phase 4)Ended earlyNCT02353754
What this trial is testing

Evaluation of the Safety and Efficacy of EXPAREL When Administered Into the TAP in Subjects Undergoing Cesarean Section

Who this might be right for
Pain
Pacira Pharmaceuticals, Inc 12
Early research (Phase 1)Study completedNCT05320094
What this trial is testing

Evaluate the Effect of Activated Charcoal With Sorbitol on the Single-dose of Mavacamten in Healthy Participants

Who this might be right for
Healthy Participants
Bristol-Myers Squibb 45
Large-scale testing (Phase 3)Active Not RecruitingNCT03528694
What this trial is testing

Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle-invasive Bladder Cancer
AstraZeneca 1,018
Testing effectiveness (Phase 2)Looking for participantsNCT05190094
What this trial is testing

Prediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Metastatic Women With Luminal, HER2 Negative Advanced Breast Cancer, Using Infrared Laser Spectroscopy Analysis on Liquid Biopsies.

Who this might be right for
Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer
International Cancer Research Group, United Arab Emirates 80
Next Page